Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from MyHealthChecked PLC ( (GB:FORF) ).
Fortis Frontier PLC, an AIM-quoted cash shell that formerly operated as diagnostics group MyHealthChecked PLC, has no active trading business following the sale of its subsidiary Concepta Diagnostics and is focused on identifying new strategic opportunities. The board is reviewing options to leverage its listed status and capital base to pursue transactions that could restore operating activities and drive returns for shareholders.
The company has repurchased 85,000 shares, about 0.16% of its capital, at 8p per share and intends to cancel them, reducing the issued share count to 51,600,827 and marginally increasing remaining investors’ proportional holdings. Fortis Frontier has also appointed Singer Capital Markets as its corporate broker, following the transfer of the Dowgate Capital team, while retaining SPARK Advisory Partners as nominated adviser, ensuring continuity of market support during its strategic review phase.
The most recent analyst rating on (GB:FORF) stock is a Sell with a £8.00 price target. To see the full list of analyst forecasts on MyHealthChecked PLC stock, see the GB:FORF Stock Forecast page.
Spark’s Take on GB:FORF Stock
According to Spark, TipRanks’ AI Analyst, GB:FORF is a Neutral.
The score is driven primarily by weak financial performance (steep revenue decline, negative gross profit, and cash burn in 2024), with only partial support from a low-debt balance sheet. Technicals add pressure with a clear downtrend and negative MACD, while valuation is difficult to justify due to negative earnings and no dividend support.
To see Spark’s full report on GB:FORF stock, click here.
More about MyHealthChecked PLC
Fortis Frontier PLC, formerly MyHealthChecked PLC, is now an AIM Rule 15 cash shell on London’s AIM market after selling its trading subsidiary, Concepta Diagnostics Limited, in November 2025. Having exited its previous diagnostics operations, the board is evaluating strategic options to deploy its cash resources and maximise shareholder value through potential acquisitions or reverse takeovers.
Average Trading Volume: 47,899
Technical Sentiment Signal: Sell
Current Market Cap: £3.99M
For a thorough assessment of FORF stock, go to TipRanks’ Stock Analysis page.